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ABSTRACT
Background: Whether antenatal and neonatal vitamin D status have
clinical relevance in fracture prevention has not been examined extensively,
although observational studies indicate that fetal life may be a sensitive
period in relation to bone growth and mineralization during childhood.
Objective: We examined whether 25-hydroxyvitamin D3 [25(OH)D3]
concentrations in stored neonatal dried blood spot (DBS) samples are
associated with pediatric fracture risk. We hypothesized that in par-
ticular, low neonatal vitamin D status may be a risk factor for fracture
incidence among children.
Design: In a register-based case-cohort study design, the case
group was composed of 1039 individuals who were randomly
selected from a total of 82,154 individuals who were born during
1989–1999 and admitted to a Danish hospital with a fracture of the
forearm, wrist, scaphoid bone, clavicle, or ankle at age 6–13 y. The
subcohort was composed of 1600 individuals randomly selected
from all Danish children born during 1989–1999. The neonatal
25(OH)D3 concentrations in DBS samples were assessed by using
highly sensitive chromatography-tandem mass spectrometry.
Results: The mean 6 SD 25(OH)D3 concentration for all subjects was
27.7 6 18.9 nmol/L [median (IQR): 23.5 nmol/L (13.3, 37.3 nmol/L)]
and showed significant monthly variation (P , 0.0001) with the highest
values in July and August. Individuals in the middle quintile of neonatal
25(OH)D3 had lower odds of sustaining a fracture than did those in the
lowest quintile (adjusted OR: 0.75; 95% CI: 0.58, 0.96), but a global test
did not show any significant overall association (adjusted P = 0.13).
Conclusions: This study suggested that neonatal vitamin D status
does not influence subsequent fracture risk in childhood. This is in
accordance with studies that report no association between antenatal
maternal vitamin D status and childhood fractures. Further studies are
needed to examine fracture risk in relation to prenatal vitamin D
status in a randomized controlled setting. Am J Clin Nutr
2017;106:155–61.
Keywords: fractures, vitamin D, dried blood spots, epidemiology,
osteoporosis, development
INTRODUCTION
Globally, the fracture incidence of the forearm, hand, and foot is
high among healthy children, but it varies across countries, ages,
sexes, and sites (1–5). Multiple factors contribute to the increased
risk of pediatric fractures, such as low bone mass; socioeconomic
status; childhood obesity and lifestyle, i.e., physical activity (risk-
taking behavior); and diet composition (6–8). However, whether
antenatal and neonatal vitamin D status has clinical relevance in
fracture prevention has not been examined extensively, and only a
few studies, to our knowledge, have related maternal vitamin D
status to offspring fracture risk and found no association (9, 10).
However, in a sensitivity analysis in the Danish Fetal Origins
1988 cohort among 850 mother-offspring pairs, Petersen et al. (9)
found a borderline inverse association between 25-hydroxyvitamin
D [25(OH)D] as a continuous variable and offspring forearm
fractures (P = 0.054), but there was no association when 25(OH)D
concentrations were categorized according to clinical cutoff values.
On the other hand, observational studies have examined in-
trauterine vitamin D status (or proxy measures of vitamin D) and
long-term bone growth and density among offspring, finding
either a direct (11–13) or no association (14). The studies were
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primarily carried out in Caucasian children; however, the studies
differed in several respects, such as the study design, the vitamin
D assessment method, the geographical latitude of the country
of the study population, and age range of the offspring at the
outcome measurements.
To our knowledge, no studies have examined neonatal vitamin
D status in relation to pediatric fracture risk, yet in Denmark we
have optimal opportunities for studying such associations with
access to the comprehensive and complete national health reg-
isters with long follow-up combined with systematically col-
lected biological material.
Recently, 25(OH)D measured from dried blood spots (DBSs)
collected in the context of the American or European newborn-
screening programs for phenylketonuria have been used to exam-
ine associations between neonatal 25(OH)D concentration and the
development of numerous other outcomes, such as schizophrenia
(15), childhood brain tumor risk (16), type 1 diabetes (17, 18),
multiple sclerosis (19, 20), autism (21), inflammatory bowel disease
(22), and cardiovascular disease risk markers (23), but measured
neonatal 25(OH)D concentrations from DBSs have not been pre-
viously compared among pediatric fracture cases and controls.
We used a case-cohort sampling design to compare 25(OH)D3
concentrations in neonatal DBS samples retrieved from the
Danish Biological Specimen Bank for Neonatal Screening for
individuals who developed fractures and for a random subcohort.
METHODS
Participants
The Danish Civil registration system was used to identify all
live-born children during 1981–2002 (n = 1,360,466), and a
random subcohort thereof was sampled for 25(OH)D analyses to
be used across the D-tect studies (n = 3585) (24). Individuals
from twin or multiple births were allowed in the sample. The
Danish National Patient Registry (NPR) was used as the source
to assess fracture outcome. The NPR is a mandatory nationwide
health registry that was established in 1977. There have been
important changes over time in the information reported to the
NPR. Most importantly for our data, mandatory registration of
outpatients and patients from emergency rooms was initiated in
1995 (25), whereas before 1995 it was only mandatory to reg-
ister hospitalized fracture cases. The result was a substantial
increase in the number of fracture cases registered from 1995
onward. To avoid this sudden increase in registered fracture
cases, in combination with a prespecified age group of interest
(6–13 y), we selected individuals only from the main subcohort
who were live-born during 1 January 1989–31 December 1999
in Denmark and had DBS cards with sufficient material for
analysis and available vitamin D results (n = 1600). Also, a
random sample was selected of 1039 fracture cases from a total
of 82,154 fracture cases who had been admitted to the hospital
with a fracture of the forearm, wrist, or scaphoid bone [In-
ternational Classification of Diseases, 10th edition (ICD-10):
S52, S62.0]; the clavicle (ICD-10: S42.0); or the ankle (ICD-10:
S82.5, S82.6, S82.8), because these sites are the most common
among European children (5). For the present study, informa-
tion on the cause of fracture had not been assessed from the
NPR. The NPR includes diagnosis codes and procedure codes
for all treatments and contains outpatient and emergency room
contacts (26). The fractures occurred when the children were
6–13 y old. If the child had .1 fracture admission, we counted
only the first admission. There were 4 fracture cases that were
also part of the random subcohort, which we attributed to the
random subcohort. The flowchart for the study population is
presented in Figure 1.
The Danish registers used in this study have coverage of almost
the entire population and good validity of fracture diagnosis
recordings in the NPR based on adult fracture patients with
primary hyperparathyroidism (27). The accuracy is expected to
be similar in children, because the treatment of pediatric and
adult fractures takes place in the same hospital units.
Ethical considerations
Permission to access and analyze the DBS samples from the
Biological Specimen Bank for Neonatal Screening was given by
the Danish National Committee on Biomedical Research Ethics
(journal no.: H-3-2011-126) and by the steering committee from the
biobank. Permission from the Danish Data Protection Agency was
also granted (J. no.: 2012–41-116). Anonymous register-based
studies are not required ethical approval according to Danish law.
Assessment of vitamin D status
Since 1 May 1981, neonatal DBS samples taken by heel
prick #1 wk after birth have been collected for all newborns
in Denmark. After routine screening for congenital disorders,
FIGURE 1 Flowchart of the study population. 1Dried blood spot cards
were not found, there was insufficient material for analysis, or the analysis
failed.
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residual DBS filter cards are stored at 2208C in a locked freezer
at the Biological Specimen Bank for Neonatal Screening at the
State Serum Institute (28). Previous studies have shown that
storage times of 25(OH)D3 for .20 y do not seem to bias in-
terindividual variation in concentrations for a given birth cohort
regardless of storage temperature and light exposure (29).
From the stored surplus card samples, one 3.2-mm punch,
taken halfway from the center of the blood spot was obtained.
This punch was used to measure the main circulating form of
vitamin D, neonatal 25(OH)D3, as well as 25(OH)D2 (30), but
not the C-3 epimer of 25(OH)D3.
The assay used was a highly sensitive liquid-chromatography
tandem mass-spectroscopy method run at the State Serum In-
stitute by using a modified version of the method of Eyles et al.
(29). There was acceptable precision for all measured concen-
trations for intra-assay and interassay analyses. The CV for intra-
assay and interassay variation for 25(OH)D3 ranged 7–12% and
7–20%, respectively. Laboratory investigators were blinded to
the diagnosis as well as the season of birth.
Because capillary blood during the neonatal period has sig-
nificantly higher hematocrit values compared with venous blood
(31), we adjusted the concentrations of 25(OH)D3 in the DBS
samples to equivalent serum concentrations using the following
formula: serum 25(OH)D3 nmol/L = DBS 25(OH)D3 nmol/L 3
1/[1 2 0.61 (the hematocrit fraction)] for capillary blood for
newborns (31). We omitted all the 25(OH)D2 measurements,
because only 4.5% were above the detection limit of 3 nmol/L.
The concentration of 25(OH)D3 is expressed in nmol/L.
Assessments of covariates
Information on some maternal characteristics (educational
level, ethnicity) was obtained from Denmark Statistics, and
smoking during pregnancy, age, parity, and gestational age were
obtained from the Danish National Birth Register. Educational
level was divided into 3 levels: 1) basic school 8th–10th class; 2)
general upper–secondary education, short-cycle higher educa-
tion or vocational education and training; and 3) medium- or
long-cycle higher education or bachelor. Ethnicity was defined
as maternal European or non-European origin. Hence, children
with fathers with non-European origin were considered Euro-
pean if mothers were of Western origin. There was information
on maternal smoking during pregnancy only for a subsample
of a total of 1982 individuals, of which 798 individuals were
from the case group, because information on smoking during
pregnancy is available from Danish registries for individuals
giving birth only from 1991 onward, when the collection of the
smoking information started. Since 1997, the data on smoking
during pregnancy was collected electronically; thus, the in-
formation collected during 1991–1996 may not be complete.
The smoking variable from 1991 to 1996 was grouped into
smoking and nonsmoking during pregnancy, and from 1997 and
onward the cigarette smoking was reported in the following
groups: unknown, mother not smoking, mother smokes, mother
stopped smoking in first trimester, mother stopped smoking after
first trimester, mother smokes up to 5, 6–10, 11–20, or .20
cigarettes/d. When combining these information sources, we
categorized the smoking variable into unknown, smoking, and
nonsmoking during pregnancy. Mothers were considered smokers
if they had ever smoked during pregnancy. The reporting of parity
changed during the study period. From 1973 to 1996 the register
included information on live and still births only. During this
period, we used the sum of births plus the actual births to estimate
parity. Subsequently, parity was dichotomized into primiparous
and multiparous. Maternal and gestational age were included in
the analyses as continuous variables.
Statistical analysis
In the descriptive data, the cases and the individuals from the
random subcohort were compared by using the chi-square test
for categorical variables and the 2-sample t test for continuous
variables.
Unlike the classic case-cohort design (32), only a random
sample of the fracture cases was included, and because loss to
follow-up was rare among the individuals in the subcohort (n = 9),
the data were analyzed as a case-control sample by including
only individuals with complete follow-up.
Using logistic regression, we estimated unadjusted and adjusted
ORs and 95% CIs for the risk of fractures of the forearm, wrist,
scaphoid bone, clavicle, or ankle, whichever came first, in the ages
6–13 y in relation to 25(OH)D3 as a continuous variable or as a
categorical variable (quintiles of the distribution of 25(OH)D3 in
the subcohort) to capture a potential nonlinear relation. Based on
our hypothesis that neonatal serum 25(OH)D3 concentrations are
lower among children who go on to sustain fractures in child-
hood, the lowest category was chosen as the reference. A priori,
the model was adjusted for offspring, sex, gestational age, parity,
and maternal educational level, because these factors have been
previously associated with neonatal bone mineralization (33).
Moreover, we adjusted for maternal age, because maternal age
seems to be associated with both vitamin D status during preg-
nancy as well as offspring fracture risk during childhood (34, 35).
Based on theoretical plausibility presented in the background,
potential interactions between the vitamin D quintile categories
and maternal ethnicity were examined by adding interaction
terms to the model and testing the statistical significance.
Because only a limited number of individuals had information
on smoking (n = 1982), the likelihood-ratio test was used to
estimate whether adjusting for smoking in the model would
improve the fit of the logistic model. Also, the individuals with
missing information on maternal smoking during pregnancy
were compared with the individuals with information on ma-
ternal smoking to address selection bias by using the chi-square-
test and the 2-sample t test. The 25(OH)D3 was square-root
transformed to achieve normal distribution before performing
the 2-sample t test. To further explore the role of maternal
smoking during pregnancy, sensitivity analyses were performed
on the subset with available information on smoking during
pregnancy to test if maternal smoking was associated with
fracture risk in the offspring by using logistic regression as well
as by examining the distribution of maternal smoking during
pregnancy in relation to the quintiles of the distribution of
25(OH)D3 by using the chi-square test. Also, we tested whether
there was effect modification with maternal smoking during
pregnancy by adding interaction terms to the model and testing
the statistical significance.
Because the 25(OH)D concentrations change according to the
seasonal variation in sun exposure at northern latitudes in both
pregnant women and their offspring at birth (36), we performed
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prespecified sensitivity analysis adjusting for the season of birth and
included the season of birth as an interaction term in further analysis.
The seasons were defined as November to January, February to
April, May to July, and August to October based on the seasonal
variation in serum 25(OH)D concentrations among individuals from
countries in northern latitudes (36, 37). A likelihood-ratio test was
used to estimatewhether including ethnicity or the season of birth in
the model would improve the fit of the logistic model.
Sensitivity analyses were performed to test whether there was
effect modification with sex by adding interaction terms to the
model and testing the statistical significance. A likelihood-ratio
test was used to estimate whether including sex in the model
would improve the fit of the logistic model.
Finally, global tests were performed as sensitivity analysis to
examine if there were any overall associations.
Statistical analyses were carried out in Stata version 14.1. A
P value of ,0.05 was considered significant. Data are expressed
as means 6 SDs unless otherwise specified.
RESULTS
In the entire sample, the distribution of 25(OH)D3was skewed. For
all subjects it was 27.7 6 18.9 nmol/L [median (IQR): 23.5 nmol/L
(13.3, 37.3 nmol/L)] when corrected for the hematocrit fraction in
capillary blood. As expected, 25(OH)D3 showed statistically
significant monthly variation (P , 0.001) with the highest values
in July and August and the lowest value in April among the in-
dividuals from fracture cases and subcohort combined (Figure 2).
In Table 1, background characteristics are presented for the
1039 fracture cases and the 1600 children from the subcohort.
There were no significant differences between the fracture cases
and the controls regarding sex, gestational age, birth weight,
25(OH)D3 quintile categories, parity, or maternal educational
level. There were borderline more maternal smokers among the
case group compared with the subcohort (24% compared with
20%, P = 0.05), and the individuals with missing information on
maternal smoking were born primarily in 1989 and 1990.
Also, there was a lower percentage of individuals with ma-
ternal non-European ethnic origin in the case group compared
with the subcohort (4.3% in the case group and 7.7% in the
subcohort, P , 0.001).
The odds for sustaining fractures were lower in the middle
(third) quintile of 25(OH)D3 in both the crude analysis (OR3:
0.76; 95% CI: 0.60, 0.98) and the adjusted model 2 (OR3: 0.75;
95% CI: 0.58, 0.96) (Table 2), than in the first quintile. Further
adjustment for smoking and season of birth, as well as birth weight,
showed a similar pattern as model 2 (Table 2). There was no
association between 25(OH)D3 as a continuous variable and
fracture risk (data not shown). However, the results from the
global tests did not show any significant overall associations in
any of the models (Table 2).
Maternal smoking during pregnancy as exposure did not
predict odds of fractures (OR: 1.19; 95% CI: 0.98, 1.45) but did
seem to influence the 25(OH)D3 concentrations with the use
of 25(OH)D3 concentrations both as a continuous variable
(P , 0.0001) and as quintiles of 25(OH)D3 (P , 0.001).
There was no significant interaction between categories of vi-
tamin D concentrations and ethnicity, sex, smoking, or season of
birth in relation to odds of fractures (Supplemental Figures 1–4).
DISCUSSION
In this large, population-based, randomly selected group of
children born in Denmark during 1989–1999, we found no evi-
dence of an association between neonatal 25(OH)D3 and the odds
of sustaining fractures in childhood at age 6–13 y. Moreover, we
found no interactions with ethnicity, sex, maternal smoking, or
season of birth. In the analysis with maternal smoking during
pregnancy as the exposure, the 25(OH)D3 concentrations were
lower but were not associated with the odds of fracture.
Our findings agree with results from the recent Danish Fetal
Origins 1988 Cohort study (n = 850) (9) and the Danish National
Birth Cohort study (n = 1497) (10), showing no association
between antenatal 25(OH)D concentration and risk of fractures
among the offspring during childhood. Given that the fetus relies
entirely on the maternal status (38) and that low bone mineral
density is predictive of increased fracture risk (6, 39–45), our
results are equivalent to the large observational ALSPAC (Avon
Longitudinal Study of Parents and Children) (14) and the ran-
domized controlled MAVIDOS (Maternal Vitamin D Osteopo-
rosis Study) (46) but in contrast to other observational studies that
found that prenatal vitamin D status and/or ultraviolet B exposure
was associated with skeletal strength and development (11–13).
In the interpretation of the differences in the above-mentioned
studies, one may consider the etiology of childhood fractures
(47); although the measurements of bone mass possibly capture
the underlying skeletal deficits unrelated to the occurrence of an
accident, the fracture events may characterize the degree of
trauma, which was not distinguished in any of the fracture
studies. Unfortunately, the cause of fracture was not retrieved
from the Danish National Patient Register for the present study
either, but it may be of interest for future studies.
Comparable to previous studies (48–51), our sensitivity anal-
yses suggested that in utero exposure to smoking influenced vi-
tamin D concentrations but not fracture risk. These results make
FIGURE 2 Box plot of the median 25(OH)D3 concentrations by the
month of birth of the individuals from the total study population (n = 2604).
The boxes indicate the interquartile range, the vertical lines indicate the
range, and the dots indicate outliers. The dried blood spot 25(OH)D3 con-
centrations have been corrected for the hematocrit fraction of 61% for cap-
illary blood. Test for no interaction between month of birth and sampling
status (cases versus subcohort): P = 0.48. Test for no difference in 25(OH)D3
concentrations between cases and subcohort adjusted for month of birth:
P = 0.54. 25(OH)D3, 25-hydroxyvitamin D3.
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us question whether we should adjust for maternal smoking
during pregnancy from a confounding perspective. Nevertheless,
the inclusion of smoking in model 3a did not improve the fit of
the logistic regression, and the pattern of the estimates in this
analysis was essentially similar to those from the other models.
The numerical values of 25(OH)D3 in the present study were
low [25(OH)D3: 27.46 18.5 nmol/L) compared with most other
studies using DBS samples (varied from 28.2 to 48.5 nmol/L)
(16, 17, 19, 21, 23) but, importantly, also compared with studies
measuring 25(OH)D3 in a similar subsample of Danish neonates
[McGrath et al. (15): 35.9 6 21.0 nmol/L; Nielsen et al. (20):
33.0 6 16.9 nmol/L for cases and 35.9 6 17.5 nmol/L for con-
trols]. A number of potential explanations for the low values may
be considered in the interpretation of our findings. Intervariability
between laboratories both within and between countries is to be
expected (52), especially because there are currently no quality-
assurance programs for vitamin D in DBSs. However, our labo-
ratory participates in the Vitamin D External Quality Assessment
Scheme with the equivalent-serum method. Dissimilarities in the
separation methods may be considered especially because the
C3-epiform of 25(OH)D3 was not included in our measure-
ments. This is relevant because the liquid-chromatography tandem
TABLE 1
Maternal and offspring background characteristics for individuals from the case group and the random subcohort1
Fracture cases Random subcohort
PN Value n Value
Offspring
Fracture event of forearm, wrist, scaphoid bone, clavicle,
or ankle at age 6–13 y
1039 100 1565 12.9 ,0.001
Girls 1039 50.1 1565 47.7 0.23
Gestational age, wk 1023 39.5 6 1.8 1537 39.6 6 2.0 0.28
Birth weight, g 1029 3494 6 561 1538 3497 6 578 0.87
Mean 25(OH)D3 quintiles (nmol/L) 1039 1565 0.29
1 (7.88) 22.1 19.9
2 (15.33) 21.1 19.9
3 (23.90) 17.1 19.9
4 (33.93) 20.7 20.2
5 (53.18) 19.0 20.1
Maternal
Smoking during pregnancy 1039 1565 0.05
Yes 248 23.9 311 19.9
No 550 52.9 873 55.8
Age, y 1036 28.2 6 4.6 1549 28.5 6 4.7 0.13
Multiparous, yes 1036 54.5 1548 55.7 0.57
Educational level 1014 1513 0.46
Basic school 8th–10th class 29.6 27.3
General upper–secondary education, short-cycle
higher education, or vocational education and
training
49.7 51.4
Medium or long-cycle higher education or bachelor 20.7 21.4
Immigrant background 1039 1560 0.001
European 95.7 92.3
Non-European 4.3 7.7
1Values are percentages or means6 SDs. The cases and the individuals from the subcohort were compared by using the
chi-square test for categorical variables and the 2-sample t test for continuous variables. 25(OH)D3, 25-hyrdroxyvitamin D3.
TABLE 2
ORs (95% CIs) of fractures in offspring at age 6–13 y for the concentration of 25(OH)D3 by the quintiles of the distribution of 25(OH)D3
1
Model 1 (n = 2604) Model 2 (n = 2559) Model 3a (n = 2559) Model 3b (n = 2559) Model 3c (n = 2547)
Mean 25(OH)D3 quintiles (nmol/L)
1 (7.88) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
2 (15.33) 1.03 (0.81, 1.31) 1.00 (0.78, 1.28) 1.01 (0.79, 1.30) 0.98 (0.76, 1.25) 0.99 (0.77, 1.26)
3 (23.90) 0.76 (0.60, 0.98) 0.75 (0.58, 0.96) 0.76 (0.59, 0.98) 0.72 (0.55, 0.93) 0.74 (0.57, 0.95)
4 (33.93) 0.98 (0.77, 1.24) 0.94 (0.73, 1.20) 0.96 (0.74, 1.23) 0.88 (0.68, 1.14) 0.92 (0.72, 1.18)
5 (53.18) 0.92 (0.72, 1.17) 0.89 (0.69, 1.15) 0.91 (0.70, 1.17) 0.81 (0.62, 1.07) 0.88 (0.68, 1.14)
Global test, P 0.13 0.13 0.16 0.08 0.14
1Model 1: logistic regression. Model 2: model 1 combined with adjustment for sex, gestational age, parity, maternal educational level, maternal ethnicity,
and maternal age. Model 3a: model 2 combined with adjustment for maternal smoking during pregnancy; likelihood-ratio test: P = 0.21. Model 3b: model 2
combined with adjustment for the season of birth; likelihood-ratio test: P = 0.43. Model 3c: model 2 combined with adjustment for birth weight; likelihood-
ratio test: P = 0.07. 25(OH)D3, 25-hyrdroxyvitamin D3; ref, reference.
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mass-spectroscopy assays have shown elevated concentrations of
25(OH)D3 in infants because of the presence of the C-3 epimer
of 25(OH)D3 (53). Additional explanations may be related to de-
viation from detailed guidelines of the blood collection procedure,
where the most common errors are overfillings, partial fillings, or
multiple applications on the circles on the filter paper (54); punch
position, because findings have revealed that 25(OH)D concentra-
tions differ across the spots, with the highest concentrations in the
periphery of the spots and lowest in the center (54); and/or multiple
freeze-thawing cycles, as a result of the stored DBS samples from
the 1980s being subjected to many punches in relation to analysis
in other previous research projects. Multiple freeze-thaw cycles in
serum 25(OH)D seem to be valid (55), and we assume that the
validity is also applicable to 25(OH)D measurements in DBS
samples, although this has not been formally tested.
However, we have no reason to believe that the generally low
values influenced the ranking of subjects and hence no reason to
question the validity of our associations. Indeed, the seasonal
variation in the 25(OH)D3 concentrations was well captured in
the present study for both the cases and the subcohort.
Strengths and limitations of the study
There are some strengths and limitations to the study that need
to be taken into account in the interpretation of the findings (56).
The strengths of the present study lie in the large sample size of
individuals randomly selected from the entire Danish population
coupled with the neonatal biomaterial (n = 2639). All but one (14)
of the previously published studies that we are aware of included
,1500 mother-offspring pairs. Also, apprehension regarding se-
lection bias was negligible because information on the mother-
offspring pairs in the present analyses was derived from national
registries, and the obtainment of the Danish neonatal DBS sam-
ples are close to complete. Even though we were able to adjust for
several potential confounders through the use of information from
comprehensive registers with high validity and covering the entire
Danish population, there may still be a risk of residual confounding
from variables for which we lacked information, although we ad-
justed for sociodemographic factors, such as educational level and
maternal age, as well as behavioral factors, such as parity and
maternal smoking, which may be considered proxy variables for
other life-style factors in general, including supplement use and
physical activity level (56, 57).
Implication for policy makers
Policy-making strategies in relation to primary prevention of
fractures among children cannot be derived from the results at this
point, but ongoing, randomized controlled trials with supplemen-
tation of vitamin D in pregnancy (46, 58, 59) await the first bone-
fracture outcome data in the children to properly informhealth policy.
Conclusion and future studies
Overall, neonatal vitamin D status does not seem to influence
the subsequent fracture risk in childhood. These results are in line
with results from the few previous studies that examined asso-
ciations between antenatal maternal vitamin D status and
childhood fractures. Large, randomized controlled trials with
vitamin D supplementation during pregnancy in relation to
fracture outcome are needed at this point.
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